Liang X - Search Results

1

Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer.

Zhu Z, Wang B, Bi J, Zhang C, Guo Y, Chu H, Liang X, Zhong C, Wang J. Zhu Z, et al. Among authors: liang x. Tumour Biol. 2013 Aug;34(4):2299-308. doi: 10.1007/s13277-013-0774-3. Epub 2013 Apr 19. Tumour Biol. 2013. PMID: 23605320

2

Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.

Wang J, Guo Y, Wang B, Bi J, Li K, Liang X, Chu H, Jiang H. Wang J, et al. Among authors: liang x. Mol Biol Rep. 2012 Dec;39(12):11153-65. doi: 10.1007/s11033-012-2024-y. Epub 2012 Oct 11. Mol Biol Rep. 2012. PMID: 23054001 Review.

3

Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.

Wang J, Wang B, Zhao W, Guo Y, Chen H, Chu H, Liang X, Bi J. Wang J, et al. Among authors: liang x. PLoS One. 2012;7(12):e52704. doi: 10.1371/journal.pone.0052704. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23285161 Free PMC article.

4

Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.

Chu H, Zhong C, Xue G, Liang X, Wang J, Liu Y, Zhao S, Zhou Q, Bi J. Chu H, et al. Among authors: liang x. Oncol Rep. 2013 Nov;30(5):2311-5. doi: 10.3892/or.2013.2709. Epub 2013 Aug 29. Oncol Rep. 2013. PMID: 24002698

5

Severe Immune-Related Pneumonitis With PD-1 Inhibitor After Progression on Previous PD-L1 Inhibitor in Small Cell Lung Cancer: A Case Report and Review of the Literature.

Liang X, Guan Y, Zhang B, Liang J, Wang B, Li Y, Wang J. Liang X, et al. Among authors: liang j. Front Oncol. 2019 Dec 18;9:1437. doi: 10.3389/fonc.2019.01437. eCollection 2019. Front Oncol. 2019. PMID: 31921686 Free PMC article.

6

Immune Thrombocytopenia Induced by Immune Checkpoint Inhibitors in Solid Cancer: Case Report and Literature Review.

Liu X, Liang X, Liang J, Li Y, Wang J. Liu X, et al. Among authors: liang x, liang j. Front Oncol. 2020 Dec 7;10:530478. doi: 10.3389/fonc.2020.530478. eCollection 2020. Front Oncol. 2020. PMID: 33365266 Free PMC article.

7

Histological sarcomatoid transformation in a lung adenocarcinoma patient following immune checkpoint blockade.

Liang X, Guan Y, Wang B, Liu X, Wang J. Liang X, et al. Ther Adv Med Oncol. 2024 Mar 6;16:17588359241236450. doi: 10.1177/17588359241236450. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38455710 Free PMC article.

8

Hsa_circ_0097922 promotes tamoxifen resistance and cell malignant behaviour of breast cancer cells by regulating ACTN4 expression via miR-876-3p.

Liang X, Liu X, Song Z, Zhu J, Zhang J. Liang X, et al. Clin Exp Pharmacol Physiol. 2022 Dec;49(12):1257-1269. doi: 10.1111/1440-1681.13702. Epub 2022 Sep 25. Clin Exp Pharmacol Physiol. 2022. PMID: 35856314

9

Histone demethylase retinoblastoma binding protein 2 regulates the expression of α-smooth muscle actin and vimentin in cirrhotic livers.

Wang Q, Wang LX, Zeng JP, Liu XJ, Liang XM, Zhou YB. Wang Q, et al. Among authors: liang xm. Braz J Med Biol Res. 2013 Sep;46(9):739-45. doi: 10.1590/1414-431X20132843. Epub 2013 Sep 6. Braz J Med Biol Res. 2013. PMID: 24068189 Free PMC article.

10

Fuzheng-Buyi formula for treating castration-resistant prostate cancer: A systematic review and meta-analysis.

Liang X, Peng S, Huang H, Xu J, Liu W, Wang H, Li Q. Liang X, et al. Medicine (Baltimore). 2024 Nov 8;103(45):e40275. doi: 10.1097/MD.0000000000040275. Medicine (Baltimore). 2024. PMID: 39533556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,471 results

Search Page

Filters